- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: April 2013
- Public Summary Document (PSD) April 2013 PBAC Meeting - PDF
Everolimus – April 2013
Everolimus, tablets, 2.5 mg, 5 mg and 10 mg, Afinitor®
Last updated
8 November 2023